Multicenter Study of Risk-Adapted Therapy with Dose-Adjusted EPOCH-R in Adults with Untreated Burkitt Lymphoma
Mark Roschewski, Kieron Dunleavy, Jeremy S. Abramson, Bayard L. Powell, Brian K. Link, Prapti Patel, Philip J. Bierman, Deepa Jagadeesh, Ronald T. Mitsuyasu, David Peace, Peter R. Watson, Wahid T. Hanna, Christopher Melani, Andrea N. Lucas, Seth M. Steinberg, Stefania Pittaluga, Elaine S. Jaffe, Jonathan W. Friedberg, Brad S. Kahl, Richard F. LittleNancy L. Bartlett, Michelle A. Fanale, Ariela Noy, Wyndham H. Wilson
Dive into the research topics of 'Multicenter Study of Risk-Adapted Therapy with Dose-Adjusted EPOCH-R in Adults with Untreated Burkitt Lymphoma'. Together they form a unique fingerprint.